Sellas Life Sciences Group Inc.
Featured video - SELLAS Reports Preliminary Data Showing Clinical[...]
Safety and Efficacy of Pegunigalsidase Alfa vs Agalsidase Beta on Renal[...]
Safety and efficacy of pegunigalsidase alfa vs agalsidase beta on renal[...]
01/27/2022 | Press release | Distributed by Public on 01/27/2022 20:16
Please select the service you want to use:
Smartlinks | DHI Group Inc. | News | Local News | Finance | Stock Markets | Security Markets | Derivative Securities | Stock Markets | Security Markets | Jobs and Labor | Employment Services | Company News | Shareholders | Buyback, Treasury Shares and Liquidity Agreements | Internal Dealings | Professional and Business Services | Public Companies | Employment Service Companies | New York Stock Exchange (NYSE) | Börse Frankfurt | Börse Stuttgart | BX Swiss | NYSE American | NYSE ARCA Equities | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | Nasdaq Intermarket | Investors Exchange (IEX) | NYSE Chicago
Back
Copyright ©2006-2022 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact